Abstract
The aim of the present study was examining the effects of some 1,3,5-trisubstituted-2-pyrazoline derivatives on depression, anxiety and spontaneous locomotor activity parameters of mice. None of the compounds was effective at 50 mg/kg dose whereas at 100 and 200 mg/kg, pyrazoline-benzoxazole derivative test compound 4a and pyrazoline-benzimidazole derivative test compound 4d in the series were exhibited significant antidepressant effects in modified forced swimming tests. These two pyrazolines decreased the immobility and increased the swimming times of mice without any change in climbing durations suggesting the antidepressant-like effects of the test compounds. In spite of significant antidepressant effect, none of the compounds changed the exploratory parameters in hole-board tests or total numbers of spontaneous locomotor activities in activity cage measurements at any of the applied doses. In other words, neither anxiolytic nor sedative effects induced by the test compounds. The results obtained from this study supported the previous findings reporting the antidepressant activities of pyrazoline derivative compounds. Exact mechanism of the antidepressant action exhibited in the present study need to be clarified with further detailed investigations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahn, J. H., Kim, H. M., Jung, S. H., Kang, S. K., Kim, K. R., Rhee, S. D., Yang, S. D., Cheon, H. G., and Kim, S. S., Synthesis and DP-IV inhibition of cyano-pyrazoline derivatives as potent anti-diabetic agents. Bioorg. Med. Chem. Lett., 14, 4461–4465 (2004).
Akhtar, M., Pillai K. K., and Vohora, D., Effect of thioperamide on modified forced swimming test-induced oxidative stress in mice. Basic Clin. Pharmacol. Toxicol., 97, 218–221 (2005).
Aksoz, E., Aksoz T., Bilge, S. S., Ilkaya, F., Celik, S., and Diren, H. B., Antidepressant-like effects of echo-planar magnetic resonance imaging in mice determined using the forced swimming test. Brain Res., 1236, 194–199 (2008).
Bilgin, A. A., Palaska, E., and Sunal, R., Studies on the synthesis and antidepressant activity of some 1-thiocarbamoyl-3,5-diphenyl-2-pyrazolines. Arzneimittelforsch., 43, 1041–1044 (1993).
Chimenti, F., Bolasco, A., Manna, F., Secci, D., Chimenti, P., Granese, A., Befani, O., Turini, P., Cirilli, R., La Torre, F., Alcaro, S., Ortuso, F., and Langer, T., Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors. Curr. Med. Chem., 13, 1411–1428 (2006).
Cryan, J. F., Markou, A., and Lucki, I., Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci., 23, 238–245 (2002).
Detke, M. J. and Lucki, I., Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav. Brain Res., 73, 43–46 (1996).
Devoize, J. L., Rigal, F., Eschalier, A., Trolese, J. F., and Renoux, M., Influence of naloxone on antidepressant drug effects in the forced swimming test in mice. Psychopharmacology (Berl)., 84, 71–75 (1984).
Fiore, M., Alleva, E., Moroni, R., and Aloe, L., Infection with Schistosoma mansoni in mice induces changes in nociception and exploratory behavior. Physiol. Behav., 65, 347–353 (1998).
Gok, S., Demet, M. M., Özdemir, A., and Turan-Zitouni, G., Evaluation of antidepressant-like effect of 2-pyrazoline derivatives. Med. Chem. Res. doi: 10.1007/s00044-009-9176-x.
Gökhan, N., Yeþilada, A., Uçar, G., Erol, K., and Bilgin, A. A., 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: Synthesis and evaluation as MAO inhibitors. Arch. Pharm., 336, 362–371 (2003).
Gökhan-Kelekçi, N., Koyunoðlu, S., Yabanoðlu, S., Yelekçi, K., Ozgen, O., Uçar, G., Erol, K., Kendi, E., Yeþilada, A., New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. Bioorg. Med. Chem., 17, 675–689 (2009).
Jayaprakash, V., Sinha, B. N., Ucar, G., and Ercan, A., Pyrazoline-based mycobactin analogues as MAO-inhibitors. Bioorg. Med. Chem. Lett., 18, 6362–6368 (2008).
Kaplanclkll, Z. A., Turan-Zitouni, G., Ozdemir, A., Devrim Can, O., and Chevallet, P., Synthesis and antinociceptive activities of some pyrazoline derivatives. Eur. J. Med. Chem., 44, 2606–2610 (2009).
Karthikeyan, M. S., Holla, B. S., and Kumari, N. S., Synthesis and antimicrobial studies on novel chloro-fluorine containing hydroxy pyrazolines. Eur. J. Med. Chem., 42, 30–36 (2007).
Kennedy, S. E., Koeppe, R. A., Young, E. A., Zubieta, J. K., Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch. Gen. Psychiatry., 63, 1199–1208 (2006).
Nakatomi, Y., Yokoyama, C., Kinoshita, S., Masaki, D., Tsuchida, H., Onoe, H., Yoshimoto, K., and Fukui, K., Serotonergic mediation of the antidepressant-like effect of the green leaves odor in mice. Neurosci Lett., 436, 167–170 (2008).
Navinés, R., Martín-Santos, R., Gómez-Gil, E., Martínez de Osaba, M. J., Gastó, C., Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response. Prog. Neuropsychopharmacol. Biol. Psychiatry., 32, 1804–1809 (2008).
Ouyang, G., Cai, X. J., Chen, Z., Song, B. A., Bhadury, P. S., Yang, S., Jin, L. H., Xue, W., Hu, D. Y., and Zeng, S., Synthesis and antiviral activities of pyrazole derivatives containing an oxime moiety. J. Agric. Food Chem., 56, 10160–10167 (2008).
Ozdemir, Z., Kandilci, H. B., Gümüþel, B., Caliþ, U., and Bilgin, A. A., Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives. Eur. J. Med. Chem., 42, 373–379 (2007).
Ozdemir, Z., Kandilci, H. B., Gumusel, B., Calis, U., and Bilgin, A. A., Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-thienyl)pyrazoline derivatives. Arch. Pharm. (Weinheim)., 341, 701–707 (2008).
Özdemir, A., Turan-Zitouni, G., and Kaplanclkll, Z. A., Novel analogues of 2-pyrazoline: synthesis, characterization, and antimycobacterial evaluation. Turk. J. Chem., 32, 529–538 (2008).
Palaska, E., Aytemir, M., Uzbay, I. T., and Erol, D., Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines. Eur. J. Med. Chem., 36, 539–543 (2001).
Parmar, S. S., Pandey, B. R., Dwivedi, C., and Harbison, R. D., Anticonvulsant activity and monoamine oxidase inhibitory properties of 1,3,5-trisubstituted pyrazolines. J. Pharm. Sci., 63, 1152–1155 (1974).
Rajendra Prasad, Y., Lakshmana Rao, A., Prasoona, L., Murali, K., and Ravi Kumar, P., Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2-hydroxy naphthalen-1-yl)-1,5-diphenyl-2-pyrazolines. Bioorg. Med. Chem. Lett., 15, 5030–5034 (2005).
Rathish, I. G., Javed, K., Ahmad, S., Bano, S., Alam, M. S., Pillai, K. K., Singh, S., and Bagchi, V., Synthesis and anti-inflammatory activity of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide. Bioorg. Med. Chem. Lett., 19, 255–258 (2009).
Soni, N., Pande, K., Kalsi, R., Gupta, T. K., Parmar, S. S., and Barthwal, J. P., Inhibition of rat brain monoamine oxidase and succinic dehydrogenase by anticonvulsant pyrazolines. Res. Commun. Chem. Pathol. Pharmacol., 56, 129–132 (1987).
Tabarelli, Z., Rubin, M. A., Berlese, D. B., Sauzem, P. D., Missio, T. P., Teixeira, M. V., Sinhorin, A. P., Martins, M. A. P., Zanatta, N., Bonacorso, H. G., and Mello, C..F., Antinociceptive effect of novel pyrazolines in mice. Braz. J. Med. Biol. Res., 37, 1531–1540 (2004).
Takeda, H., Tsuji, M., and Matsumiya, T., Changes in headdipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J. Pharmacol., 350, 21–29 (1998).
Tanaka, M. and Telegdy, G., Involvement of adrenergic and serotonergic receptors in antidepressant-like effect of Urocortin 3 in a modified forced swimming test in mice. Brain Res. Bull., 77, 301–305 (2008).
Tejedor-Real, P., Micó, J. A., Maldonado, R., Roques, B. P., and Gibert-Rahola, J., Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacol. Biochem. Behav., 52, 145–152 (1995).
Ucar, G., Gokhan, N., Yesilada, A., Bilgin, A. A., 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson’s and Alzheimer’s diseases. Neurosci. Lett., 382, 327–331 (2005).
Votava, M., Hess, L., Slíva, J., Krsiak, M., and Agová, V., Dexmedetomidine selectively suppresses dominant behavior in aggressive and sociable mice. Eur. J. Pharmacol., 523, 79–85 (2005).
Wang, A. X., Xie, Q., Lane, B., Mollison, K. W., Hsieh, G. C., Marsh, K., Sheets, M. P., Luly, J. R., and Coghlan, M. J., Synthesis and immunosuppressant activity of pyrazole carboxamides. Bioorg. Med. Chem. Lett., 8, 2787–2792 (1998).
Zangen, A., Nakash, R., Roth-Deri, I., Overstreet, D. H., and Yadid, G., Impaired release of â-endorphin in response to serotoninin a rat model of depression. Neurosciences, 110, 389–393 (2002).
Zsoldos-Mády, V., Csámpai, A., Szabó, R., Mészáros-Alapi, E., Pásztor, J., Hudecz, F., and Sohár, P., Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines. Chem. Med. Chem., 1, 1119–1125 (2006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Can, Ö.D., Özkay, Ü.D., Kaplancıklı, Z.A. et al. Effects of some 1,3,5-trisubstitued-2-pyrazoline derivatives on depression and anxiety parameters of mice. Arch. Pharm. Res. 32, 1293–1299 (2009). https://doi.org/10.1007/s12272-009-1915-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-009-1915-5